Meibomian Gland Dysfunction: Intense Pulsed Light Therapy in Combination with Low-Level Light Therapy as Rescue Treatment

    June 2021 in “ Medicina ”
    Leonidas Solomos, Walid Bouthour, Ariane Malclès, Gabriele Thumann, Horace Massa
    Studysummary This study found that combined intense pulsed light and low-level light therapy significantly improved ocular surface outcomes and quality of life for patients with meibomian gland dysfunction and dry eye disease. Our plain-language summary of this paper — not a Tressless recommendation.
    This study evaluated the Eye-light® device, combining intense pulsed light therapy and low-level light therapy, for treating meibomian gland dysfunction (MGD) and dry eye disease (DED) in 22 eyes from 11 patients over 6 weeks. Significant improvements were observed in the Ocular Surface Disease Index (OSDI) score, meibomian gland dysfunction score, tear break-up time, lid margin vascularity, and gland orifice plugging. The treatment was found to be a beneficial adjunctive therapy, enhancing patients' quality of life without side effects. However, the study's retrospective design and lack of a control group were limitations, suggesting the need for further research.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results